News

The new ABLE 3D Magnetic Stir and Disposable Bioreactor System from AMSBIO provides cost-effective, lab-scale production of induced pluripotent stem (iPS) cell spheroid culture.

Are you a scientist or clinician working in the wonderful world of cell and gene therapy and drug development? If yes, this is the podcast for you!


During this episode of 'Conversations in Drug Development' you can learn more about the 'Recent Trends in Oncology Drug Development'.


LISTEN NOW 


Aimed at in-house lawyers who are not already experts in a given technology but would like to know more, each of these three sessions will give an overview of the science as well as jargon-busting tips, followed by some legal considerations and hot topics.

To find out more and register, click here - https://www.bristows.com/viewpoint/events/



  • SemaCyte Microcarrier Platform addresses limitations within adherent cell assays to accelerate the pace of in vitro drug discovery

  • Early access will further validate the technology and provide feedback on applicability across customer workflows


 


  • Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity

  • Peer-reviewed data demonstrates the sensitivity of INDUCE-seq DNA break mapping platform, in identifying topology-related off-target events across the genome in cells


 

Click here to view the October 2023 edition of The Meeting Place


To achieve Net Zero in the UK, thousands of businesses and millions of individuals need to change the way they do things every day. Innovate UK EDGE has partnered with sustainability innovators Greenr to give your company a toolkit of practical strategies that will launch you on your Net Zero journey. Find out how action on sustainability can also enhance your reputation, boost employee satisfaction and help with recruitment and retention. Turn your Net Zero ambitions into practical actions and get results!

Tessellate BIO Emerges from Stealth


The Next Generation Synthetic Lethality Precision Oncology Company

Bruntwood SciTech, the UK’s leading specialist property provider, founded by Legal & General and Bruntwood in 2018 to support the growth of the life science and tech sectors, has secured £500 million of additional investment and welcomed the UK’s largest local authority pension fund, Greater Manchester Pension Fund (GMPF), to the partnership. GMPF is the first local government pension scheme to make a direct and active investment into a UK-wide science, tech and innovation specialist property platform.

Pages